Clinical impact of complex percutaneous coronary intervention in patients with coronary artery disease

Hirohisa Endo1, Tomotaka Dohi2, Katsumi Miyauchi1

  • 1Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Insights

Complex percutaneous coronary intervention (C-PCI) involves intricate procedures but does not worsen mid-term clinical outcomes. Patients undergoing C-PCI experienced similar rates of death and major adverse cardiac events compared to non-complex PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) is a key revascularization technique.
  • Complex PCI (C-PCI) requires advanced skills for challenging coronary anatomies.
  • The clinical impact of C-PCI on patient outcomes remains incompletely understood.

Purpose of the Study:

  • To investigate the association between C-PCI and mid-term clinical outcomes.
  • To compare hard clinical endpoints in patients undergoing C-PCI versus non-complex PCI.
  • To evaluate the prognostic significance of complex PCI procedures.

Main Methods:

  • A cohort of 1062 patients undergoing PCI with newer-generation drug-eluting stents was analyzed.
  • Patients were stratified into C-PCI (n=358) and non-complex PCI (non-C-PCI, n=704) groups.
  • C-PCI was defined by specific procedural criteria including multiple vessels/lesions, stent length, chronic total occlusion, unprotected left main, or rotational atherectomy.

Main Results:

  • The C-PCI group exhibited a significantly higher baseline SYNTAX score, indicating greater anatomical complexity.
  • Kaplan-Meier analysis revealed no significant differences in cumulative incidences of all-cause death (p=0.12) or major adverse cardiac and cerebrovascular events (MACCE) (p=0.64) between groups.
  • Multivariable Cox analysis confirmed that C-PCI did not adversely affect mid-term clinical outcomes.

Conclusions:

  • Complex PCI procedures, despite anatomical challenges, are associated with comparable mid-term clinical outcomes to non-complex PCI.
  • The technical complexity of C-PCI does not appear to translate into worse hard clinical endpoints.
  • These findings support the safety and efficacy of C-PCI in managing patients with complex coronary artery disease.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
372